The FDA outlined details of a study today that it said might allow animal drug developers to conduct certain types of research without the use of dogs.
“The aim is this: by doing a single study to help establish a non-animal-based model, we can potentially replace much of the need to use dogs in future trials with new informatics tools,” FDA Commissioner Scott Gottlieb, MD, said in a release. “In short, our goal is to do one single study involving a small number of dogs — where the dogs will only be subject to minimally invasive blood sampling, and adopted as pets at the completion of the short trial — to eliminate the need for the use of dogs in certain types of future studies, some where they might have been euthanized.”
No commercial support for this activity.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.